Schedule 13G ownership disclosure

Qualigen Therapeutics, Inc.

Security class unavailable · CUSIP: 74754R103

Event date: 2021-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,960,000
Percent of class
5.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000102
Form type
SC 13G
Filer
AIxCrypto Holdings, Inc.
CIK
CIK 1460702
Filed
Dec 06, 2021
Reporting period
Nov 29, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub